GILD vs INCY
Gilead Sciences vs Incyte — AI-powered side-by-side comparison
| Metric | GILD | INCY |
|---|---|---|
| AI Score | 60 | 68 |
| Price | $130.19 | $119.47 |
| P/E Ratio | 17.55× | 14.70× |
| ROE | 0.4% | 0.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 0.9% |
| Debt / Equity | 0.94× | 0.01× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 44.8 | 49.5 |
| Beta | 0.343 | 0.758 |
| Expected Upside | +20.8% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
INCY Full Analysis